FDA Announces Recall of Blood Pressure Medications Over High Levels of Possible Carcinogenic—Here's What to Do

The voluntary recall by Lupin Pharmaceuticals involves Irbesartan tablets as well as its Irbesartan and Hydrochlorothiazide tablets.